RADICAVA (edaravone injection), for intravenous use

RADICAVA is indicated for the treatment of amyotrophic lateral sclerosis (ALS). Brand: RADICAVA (edaravone injection), for intravenous use Initial U.S. Approval: 2017

Home |  (edaravone injection), for intravenous use

RADICAVA (edaravone injection) Price In India and Overseas
RADICAVA (edaravone injection)

Submit a request to access drug used to treat, diagnose or prevent serious or life-threatening conditions.We’ll get back to you within 1 business days!

For Indian Patient Enquiry under NPP.

For any urgent inquiries or assistance needed, please reach out to our Support Team. Rest assured, we will respond within 24 hours, from Monday to Saturday, during the hours of 9:00 A.M to 18:00 PM.

RADICAVA (edaravone injection)

Edaravone, sold under the brand name Radicava among others, is a medication used to treat stroke and amyotrophic lateral sclerosis (ALS).

Radicava (edravone) injection and Radicava ORS, an oral suspension, are used to treat amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease. ALS is a progressive neurodegenerative disease, which affects nerve cells in the spinal cord and brain. Active ingredient: edaravone Inactive ingredients: L-cysteine hydrochloride hydrate, sodium bisulfite, sodium chloride, phosphoric acid and sodium hydroxide.

Edaravone is used to help people recover from stroke in Japan, and is used to treat ALS in the US and Japan.. The U.S. Food and Drug Administration (FDA) considers it to be a first-in-class medication.

Drug (Brand / Generic): RADICAVA / edaravone
Current Indications: amyotrophic lateral sclerosis (ALS)
Marketed by:: MT Pharma America, Inc.
Approval Date: 2017

Available as (Form & Strength):
Injection: 30 mg/100 mL in a single-dose polypropylene bag.

For more highlights of prescribing information regarding Indications and usage, dosage and administration, dosage forms and strengths, patient counseling information and medication guide. Click Here

Alleviare Life Sciences

About Us

Alleviare Life Sciences Pvt. Ltd. (India) serves as a facilitator for medical and pharmaceutical products, commencing its operations in 2005. Headquartered in Delhi, India, Alleviare operates nationwide, providing a range of comprehensive services to patients, doctors, hospitals, and government healthcare facilities.

Our specialization lies in facilitating access to medicines, leveraging our expertise in sourcing and providing documentation assistance for programs such as Named Patient Program, Managed Access Program, and Early Access Program. We take pride in ensuring smooth and efficient access to medications for those who require them.

Alleviare India, a certified pharmaceutical facilitator / supplier / importer of specialty medicines or drugs based in India.